These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 24377552)

  • 1. Effects of arsenic trioxide alone and in combination with bortezomib in multiple myeloma RPMI 8266 cells.
    Elmahi AY; Niu C; Li W; Li D; Wang GJ; Hao SS; Cui JW
    Asian Pac J Cancer Prev; 2013; 14(11):6469-73. PubMed ID: 24377552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of arsenic trioxide combined with bortezomib on apoptosis of multiple myeloma cell line KM3 and its mechanisms.
    Ge QF; Ouyang GF; Chen Y; Zhang Y; Mu QT; Lu Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Feb; 20(1):112-5. PubMed ID: 22391178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Homoharringtonine combined arsenic trioxide induced apoptosis in human multiple myeloma cell line RPMI 8226: an experimental research].
    Zhou XJ; Zhou YH; Chen XH; Qian WB
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jun; 33(6):834-9. PubMed ID: 23980369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic anticancer effects of arsenic trioxide with bortezomib in mantle cell lymphoma.
    Jung HJ; Chen Z; McCarty N
    Am J Hematol; 2012 Dec; 87(12):1057-64. PubMed ID: 22965904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic antiproliferative effect of arsenic trioxide combined with bortezomib in HL60 cell line and primary blasts from patients affected by myeloproliferative disorders.
    Canestraro M; Galimberti S; Savli H; Palumbo GA; Tibullo D; Nagy B; Guerrini F; Piaggi S; Cine N; Metelli MR; Petrini M
    Cancer Genet Cytogenet; 2010 Jun; 199(2):110-20. PubMed ID: 20471514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of arsenic trioxide combined with bortezomib on proliferation, apoptosis and beta-catenin level in myeloma cell lines].
    Zhou LL; Fu WJ; Yuan ZG; Wang DX; Hou J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):84-8. PubMed ID: 18315906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HL-60 cell apoptosis induced by bortezomib alone or in combination with arsenic trioxide in vitro].
    Sun QX; Meng FY; Fu YB; Li L; Tian S
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jul; 27(7):1022-5. PubMed ID: 17666343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Apoptosis-inducing effect of valproic acid combined with arsenic trioxide on RPMI 8226 cells and its mechanism].
    Wang XN; Zhang M
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1016-21. PubMed ID: 25130820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced antimyeloma cytotoxicity by the combination of arsenic trioxide and bortezomib is further potentiated by p38 MAPK inhibition.
    Wen J; Feng Y; Huang W; Chen H; Liao B; Rice L; Preti HA; Kamble RT; Zu Y; Ballon DJ; Chang CC
    Leuk Res; 2010 Jan; 34(1):85-92. PubMed ID: 19608275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Synergistic effects of arsenic trioxide and proteasome inhibitor bortezomib on apoptosis induction in Raji cell line].
    He Y; Yang JM; Wang JM; Zhou H; Lü SQ; Hu XX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):794-8. PubMed ID: 18718063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of bortezomib alone or combined with arsenic trioxide on the apoptosis of Jurkat cells and expression of livin mRNA].
    Tan DW; Sun ZQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):898-901. PubMed ID: 21867610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arsenic trioxide and proteasome inhibitor bortezomib synergistically induce apoptosis in leukemic cells: the role of protein kinase Cdelta.
    Yan H; Wang YC; Li D; Wang Y; Liu W; Wu YL; Chen GQ
    Leukemia; 2007 Jul; 21(7):1488-95. PubMed ID: 17495969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arsenic trioxide-enhanced, matrine-induced apoptosis in multiple myeloma cell lines.
    Yu Q; Chen B; Zhang X; Qian W; Ye B; Zhou Y
    Planta Med; 2013 Jun; 79(9):775-81. PubMed ID: 23700110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic trioxide mediates intrinsic and extrinsic pathways of apoptosis and cell cycle arrest in acute megakaryocytic leukemia.
    Lam HK; Li K; Chik KW; Yang M; Liu VC; Li CK; Fok TF; Ng PC; Shing MM; Chuen CK; Yuen PM
    Int J Oncol; 2005 Aug; 27(2):537-45. PubMed ID: 16010437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro effect of bortezomib alone or in combination with harringtonine or arsenic trioxide on proliferation and apoptosis of multidrug resistant leukemia cells].
    Cai YX; Meng FY; Sun QX; Fu YB; Li L
    Zhonghua Xue Ye Xue Za Zhi; 2008 Nov; 29(11):737-40. PubMed ID: 19176009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenic trioxide-mediated growth inhibition of myeloma cells is associated with an extrinsic or intrinsic signaling pathway through activation of TRAIL or TRAIL receptor 2.
    Wu X; Shi J; Wu Y; Tao Y; Hou J; Meng X; Hu X; Han Y; Jiang W; Tang S; Zangari M; Tricot G; Zhan F
    Cancer Biol Ther; 2010 Dec; 10(11):1201-14. PubMed ID: 20953137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The proapoptotic effect of zoledronic acid is independent of either the bone microenvironment or the intrinsic resistance to bortezomib of myeloma cells and is enhanced by the combination with arsenic trioxide.
    Abeltino M; Bonomini S; Bolzoni M; Storti P; Colla S; Todoerti K; Agnelli L; Neri A; Rizzoli V; Giuliani N
    Exp Hematol; 2011 Jan; 39(1):55-65. PubMed ID: 20977926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of c-Met enhances sensitivity to bortezomib in human multiple myeloma U266 cells via inhibiting Akt/mTOR activity.
    Que W; Chen J; Chuang M; Jiang D
    APMIS; 2012 Mar; 120(3):195-203. PubMed ID: 22339676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [NB4 cell apoptosis induced by bortezomib combined with As(2)O(3) and its mechanism].
    Chen XW; Xia HL; Xia RX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):348-52. PubMed ID: 21518486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of arsenic trioxide combined with bortezomib on proliferation and apoptosis of K562 cells and their mechanism].
    Wu HY; Wang SM; Huang JQ; Hao LM; Li XM; Wei LY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1361-4. PubMed ID: 23257433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.